We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Latest publication: One Health Index Calculator for India
We are excited to share our recent publication where researchers have developed... read more
On rising COVID-19 cases in several countries
There is need to exercise caution and follow COVID19 appropriate norms &... read more
TIGS and the Avestagenome Project® partner to advance research in Rare Genetic Disorders
The Avestagenome Project® International Pvt. Ltd. (AGENOME) & Avesthagen Limited, in partnership... read more
Healthcare to agriculture: How genome revolution could be game changer
One of the biggest developments in science has been the precise deciphering... read more
MoU signing with Institute of Bioinformatics and Applied Biotechnology (IBAB)
We are glad to announce an institutional MoU with Institute of Bioinformatics... read more
The impact of Next Generation Sequencing on human health and agriculture
Next-Generation Sequencing (NGS) denotes high-throughput sequencing in a massively parallel fashion that... read more
Detailed genome map of malaria vector
Scientists have unveiled the detailed genome of the malaria mosquito vector, revealing... read more
Award to Dr. Mansi Malik
Dr. Mansi Malik, Scientist at TIGS recently won the 'Best Turbo Talk... read more
Mosquito surveillance must include non-residential urban environments
Dr. Farah Ishtiaq and teams' recent work on outdoor mosquito surveillance highlights... read more
Talk on ‘Importance of Environmental Surveillance in India’ by Dr. Farah Ishtiaq
Dr. Farah Ishtiaq, Principal Scientist at TIGS gave a talk on 'Importance... read more

